Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Depression in Parkinson's disease: biogenic amines in CSF of “de novo” patients

Identifieur interne : 002192 ( Main/Exploration ); précédent : 002191; suivant : 002193

Depression in Parkinson's disease: biogenic amines in CSF of “de novo” patients

Auteurs : W. Kuhn [Allemagne] ; Th. Müller [Allemagne] ; M. Gerlach [Allemagne] ; E. Sofic [Allemagne] ; G. Fuchs [Allemagne] ; N. Heye [Allemagne] ; R. Prautsch [Allemagne] ; H. Przuntek [Allemagne]

Source :

RBID : ISTEX:6E0605B28CDD96157685B81E19760DDBF36E1846

Abstract

Summary: Introduction. Etiology of depression in Parkinsons disease (PD) is associated with serotonergic dysfunction. Previous studies, supporting this hypothesis, were performed on patients treated with antiparkinsonian drugs. To eliminate the influence of parkinsonian drug therapy and to elucidate significance of different biochemical pathways in PD associated with depression we determined levels of biogenic amines in cerebrospinal fluid (CSF) of 26 untreated “de novo” Parkinsonian patients.Material and methods. Patients were scored with the Hamilton depression scale (HD) and subdivided into groups with HD score ≥ 18 and HD score <18. Diagnosis of depression was made according to DSM III R. Both groups were matched for age and motor disability.Results. In both groups no significant differences appeared between CSF levels of dopamine, noradrenaline, 3,4-dihydroxyphenylacetic acid, homovanillic acid, 3-methoxy-4-hydroxyphenylglycol and 5-hydroxyindole acetic acid, determined by high-performance liquid chromatography.Discussion. In contrast to previous studies on treated Parkinsonian patients no sign of altered serotonin metabolism especially in context with severity of depression in early stages of PD was found. Due to our results, we suggest, that biochemical markers of depression in CSF of PD may be influenced by antiparkinsonian therapy and that depression in PD may respond to serotonin reuptake inhibitors mainly in later stages of PD.

Url:
DOI: 10.1007/BF01271258


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Depression in Parkinson's disease: biogenic amines in CSF of “de novo” patients</title>
<author>
<name sortKey="Kuhn, W" sort="Kuhn, W" uniqKey="Kuhn W" first="W." last="Kuhn">W. Kuhn</name>
</author>
<author>
<name sortKey="Muller, Th" sort="Muller, Th" uniqKey="Muller T" first="Th." last="Müller">Th. Müller</name>
</author>
<author>
<name sortKey="Gerlach, M" sort="Gerlach, M" uniqKey="Gerlach M" first="M." last="Gerlach">M. Gerlach</name>
</author>
<author>
<name sortKey="Sofic, E" sort="Sofic, E" uniqKey="Sofic E" first="E." last="Sofic">E. Sofic</name>
</author>
<author>
<name sortKey="Fuchs, G" sort="Fuchs, G" uniqKey="Fuchs G" first="G." last="Fuchs">G. Fuchs</name>
</author>
<author>
<name sortKey="Heye, N" sort="Heye, N" uniqKey="Heye N" first="N." last="Heye">N. Heye</name>
</author>
<author>
<name sortKey="Prautsch, R" sort="Prautsch, R" uniqKey="Prautsch R" first="R." last="Prautsch">R. Prautsch</name>
</author>
<author>
<name sortKey="Przuntek, H" sort="Przuntek, H" uniqKey="Przuntek H" first="H." last="Przuntek">H. Przuntek</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:6E0605B28CDD96157685B81E19760DDBF36E1846</idno>
<date when="1996" year="1996">1996</date>
<idno type="doi">10.1007/BF01271258</idno>
<idno type="url">https://api.istex.fr/document/6E0605B28CDD96157685B81E19760DDBF36E1846/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">001523</idno>
<idno type="wicri:Area/Main/Curation">001298</idno>
<idno type="wicri:Area/Main/Exploration">002192</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Depression in Parkinson's disease: biogenic amines in CSF of “de novo” patients</title>
<author>
<name sortKey="Kuhn, W" sort="Kuhn, W" uniqKey="Kuhn W" first="W." last="Kuhn">W. Kuhn</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum</wicri:regionArea>
<wicri:noRegion>Ruhr-University Bochum</wicri:noRegion>
<wicri:noRegion>Ruhr-University Bochum</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Muller, Th" sort="Muller, Th" uniqKey="Muller T" first="Th." last="Müller">Th. Müller</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum</wicri:regionArea>
<wicri:noRegion>Ruhr-University Bochum</wicri:noRegion>
<wicri:noRegion>Ruhr-University Bochum</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Gerlach, M" sort="Gerlach, M" uniqKey="Gerlach M" first="M." last="Gerlach">M. Gerlach</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum</wicri:regionArea>
<wicri:noRegion>Ruhr-University Bochum</wicri:noRegion>
<wicri:noRegion>Ruhr-University Bochum</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Psychiatry, Clinical Neurochemistry, University of Würzburg</wicri:regionArea>
<wicri:noRegion>University of Würzburg</wicri:noRegion>
<wicri:noRegion>University of Würzburg</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Sofic, E" sort="Sofic, E" uniqKey="Sofic E" first="E." last="Sofic">E. Sofic</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Psychiatry, Clinical Neurochemistry, University of Würzburg</wicri:regionArea>
<wicri:noRegion>University of Würzburg</wicri:noRegion>
<wicri:noRegion>University of Würzburg</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Fuchs, G" sort="Fuchs, G" uniqKey="Fuchs G" first="G." last="Fuchs">G. Fuchs</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Parkinson Clinic Wohlfahrt, Wolfach</wicri:regionArea>
<wicri:noRegion>Wolfach</wicri:noRegion>
<wicri:noRegion>Wolfach</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Heye, N" sort="Heye, N" uniqKey="Heye N" first="N." last="Heye">N. Heye</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum</wicri:regionArea>
<wicri:noRegion>Ruhr-University Bochum</wicri:noRegion>
<wicri:noRegion>Ruhr-University Bochum</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Prautsch, R" sort="Prautsch, R" uniqKey="Prautsch R" first="R." last="Prautsch">R. Prautsch</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum</wicri:regionArea>
<wicri:noRegion>Ruhr-University Bochum</wicri:noRegion>
<wicri:noRegion>Ruhr-University Bochum</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Przuntek, H" sort="Przuntek, H" uniqKey="Przuntek H" first="H." last="Przuntek">H. Przuntek</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum</wicri:regionArea>
<wicri:noRegion>Ruhr-University Bochum</wicri:noRegion>
<wicri:noRegion>Ruhr-University Bochum</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Journal of Neural Transmission</title>
<title level="j" type="sub">Basic neurosciences and genetics, Parkinson's disease and allied conditions, Alzheimer's disease and related disorders, biological psychiatry</title>
<title level="j" type="abbrev">J. Neural Transmission</title>
<idno type="ISSN">0300-9564</idno>
<idno type="eISSN">1435-1463</idno>
<imprint>
<publisher>Springer-Verlag</publisher>
<pubPlace>Vienna</pubPlace>
<date type="published" when="1996-12-01">1996-12-01</date>
<biblScope unit="volume">103</biblScope>
<biblScope unit="issue">12</biblScope>
<biblScope unit="page" from="1441">1441</biblScope>
<biblScope unit="page" to="1445">1445</biblScope>
</imprint>
<idno type="ISSN">0300-9564</idno>
</series>
<idno type="istex">6E0605B28CDD96157685B81E19760DDBF36E1846</idno>
<idno type="DOI">10.1007/BF01271258</idno>
<idno type="ArticleID">Art8</idno>
<idno type="ArticleID">BF01271258</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0300-9564</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Summary: Introduction. Etiology of depression in Parkinsons disease (PD) is associated with serotonergic dysfunction. Previous studies, supporting this hypothesis, were performed on patients treated with antiparkinsonian drugs. To eliminate the influence of parkinsonian drug therapy and to elucidate significance of different biochemical pathways in PD associated with depression we determined levels of biogenic amines in cerebrospinal fluid (CSF) of 26 untreated “de novo” Parkinsonian patients.Material and methods. Patients were scored with the Hamilton depression scale (HD) and subdivided into groups with HD score ≥ 18 and HD score <18. Diagnosis of depression was made according to DSM III R. Both groups were matched for age and motor disability.Results. In both groups no significant differences appeared between CSF levels of dopamine, noradrenaline, 3,4-dihydroxyphenylacetic acid, homovanillic acid, 3-methoxy-4-hydroxyphenylglycol and 5-hydroxyindole acetic acid, determined by high-performance liquid chromatography.Discussion. In contrast to previous studies on treated Parkinsonian patients no sign of altered serotonin metabolism especially in context with severity of depression in early stages of PD was found. Due to our results, we suggest, that biochemical markers of depression in CSF of PD may be influenced by antiparkinsonian therapy and that depression in PD may respond to serotonin reuptake inhibitors mainly in later stages of PD.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Allemagne</li>
</country>
</list>
<tree>
<country name="Allemagne">
<noRegion>
<name sortKey="Kuhn, W" sort="Kuhn, W" uniqKey="Kuhn W" first="W." last="Kuhn">W. Kuhn</name>
</noRegion>
<name sortKey="Fuchs, G" sort="Fuchs, G" uniqKey="Fuchs G" first="G." last="Fuchs">G. Fuchs</name>
<name sortKey="Gerlach, M" sort="Gerlach, M" uniqKey="Gerlach M" first="M." last="Gerlach">M. Gerlach</name>
<name sortKey="Gerlach, M" sort="Gerlach, M" uniqKey="Gerlach M" first="M." last="Gerlach">M. Gerlach</name>
<name sortKey="Heye, N" sort="Heye, N" uniqKey="Heye N" first="N." last="Heye">N. Heye</name>
<name sortKey="Muller, Th" sort="Muller, Th" uniqKey="Muller T" first="Th." last="Müller">Th. Müller</name>
<name sortKey="Prautsch, R" sort="Prautsch, R" uniqKey="Prautsch R" first="R." last="Prautsch">R. Prautsch</name>
<name sortKey="Przuntek, H" sort="Przuntek, H" uniqKey="Przuntek H" first="H." last="Przuntek">H. Przuntek</name>
<name sortKey="Sofic, E" sort="Sofic, E" uniqKey="Sofic E" first="E." last="Sofic">E. Sofic</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002192 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002192 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:6E0605B28CDD96157685B81E19760DDBF36E1846
   |texte=   Depression in Parkinson's disease: biogenic amines in CSF of “de novo” patients
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024